The actress is building a community of artists, thinkers and doers of all kinds, in a storied building in downtown Manhattan.
The ADEPT trial met all primary and key secondary endpoints, enrolling 106 adults with moderate-to-severe BP who were randomized to receive Dupixent 300 mg (n=53) every two weeks after an initial ...
Five times more adults on Dupixent achieved sustained disease remission at 36 weeks compared to placebo; significant reductions were also seen in disease severity and itch Dupixent also significantly ...
Five times more adults on Dupixent achieved sustained disease remission at 36 weeks compared to placebo; significant reductions were also seen in disease severity and itch Dupixent also ...
After several months, inflammatory disease medication Dupixent has finally reclaimed its spot atop the rankings for over-the-counter (OTC) and Rx brand marketing on TV. The Regeneron and Sanofi brand, ...
Dupixent late-breaking positive pivotal data in bullous pemphigoid presented at AAD Five times more adults on Dupixent achieved sustained disease remission at 36 weeks compared to placebo ...
13d
Daily Express US on MSNAngelina Jolie 'steamrolled' by Oscars snub as actress plans next roleAngelina Jolie was reportedly 'steamrolled' by Oscars snub, with the actress reportedly planning her next career steps.
(RTTNews) - Regeneron Pharmaceuticals Inc. (REGN) and Sanofi presented positive results from the pivotal ADEPT Phase 2/3 trial evaluating the investigational use of Dupixent (dupilumab) in adults ...
TheHyperHive on MSN1d
Iranian Woman “Zombie Angelina Jolie” Jailed for 10 YearsSahar Tabar, born Fatemeh Khishvand, is a young Iranian woman who gained international attention for her eerie, zombie-like ...
Shiloh Jolie Pitt looks cozy in hoodie and sweats as she goes to a dance class with a friendBy Maria Loreto Angelina Jolie proudly supports her daughter Zahara at a mother-daughter brunch for a ...
Sanofi and Regeneron have celebrated a pair of positive clinical trials in inflammatory skin disorders with blockbuster immunology therapy Dupixent that could both lead to new indications for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results